Cargando…
Biomarkers in colorectal liver metastases: Rising complexity and unknown clinical significance?
Surgical resection of the liver is the standard treatment for colorectal liver metastases, but 70% of patients still experience recurrence, resulting in limited survival. Molecular biomarkers promise guidance within the selection process of individualized treatment and provide better prognostic fore...
Autores principales: | Diener, Markus K., Fichtner‐Feigl, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316735/ https://www.ncbi.nlm.nih.gov/pubmed/34337296 http://dx.doi.org/10.1002/ags3.12454 |
Ejemplares similares
-
Proteome biology of primary colorectal carcinoma and corresponding liver metastases
por: Fahrner, Matthias, et al.
Publicado: (2021) -
Phenotypic Characterization of Colorectal Liver Metastases: Capsule versus No Capsule and the Potential Role of Epithelial Mesenchymal Transition
por: Fleig, Claudia, et al.
Publicado: (2023) -
Robotic-Assisted Surgery for Primary Hepatobiliary Tumors—Possibilities and Limitations
por: Spiegelberg, Julia, et al.
Publicado: (2022) -
The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases
por: Runkel, M., et al.
Publicado: (2021) -
The Role of Biomarkers in the Management of Colorectal Liver Metastases
por: Hewitt, Daniel Brock, et al.
Publicado: (2022)